Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

ArQule to Participate in the Jefferies London Healthcare Conference on November 20, 2019


ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, Chief Executive Officer, will participate in the Jefferies London Healthcare Conference on Wednesday, November 20, 2019 in London, UK.

About ArQule
ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and rare diseases. ArQule's mission is to discover, develop and commercialize novel small molecule drugs in areas of high unmet need that will dramatically extend and improve the lives of our patients. Our clinical-stage pipeline consists of four drug candidates, all of which are in targeted, biomarker-defined patient populations, making ArQule a leader among companies our size in precision medicine. ArQule's pipeline includes: ARQ 531, an orally bioavailable, potent and reversible dual inhibitor of both wild type and C481S-mutant BTK, in phase 2 for patients with B-cell malignancies refractory to other therapeutic options; miransertib (ARQ 092), a potent and selective inhibitor of the AKT serine/threonine kinase, in a registrational trial with cohorts in Proteus syndrome and PROS; ARQ 751, a next generation highly potent and selective AKT inhibitor, in phase 1 for patients with solid tumors with AKT1 and PI3K mutations; and derazantinib, a multi-kinase inhibitor designed to preferentially inhibit the fibroblast growth factor receptor (FGFR) family, in a registrational trial for iCCA in collaboration with Basilea and Sinovant. ArQule's current discovery efforts are focused on the identification and development of novel kinase inhibitors, leveraging the Company's proprietary library of compounds.


These press releases may also interest you

at 10:00
White Knight Press has just released Photographer's Guide to the Nikon Coolpix P950, a full-color, detailed guide book covering the menus, features, controls, and operation of the Nikon Coolpix P950 superzoom camera. This book, by Alexander S. White,...

at 08:05
Incyte today announced the first presentation of Phase 3 data for ruxolitinib cream in atopic dermatitis at the Revolutionizing Atopic Dermatitis Virtual Symposium. The Phase 3 TRuE-AD program, which includes the TRuE-AD1 and TRuE-AD2 studies, is...

at 08:00
As people in America and around the world continue to practice safety within their homes; in an effort to control the spread of this virus we present to you a Def Comedy Jam in support of communities in need during this COVID-19 Public Health Crisis,...

at 07:00
Plataine, a leading provider of Industrial IoT (IIoT) and AI-based software for advanced manufacturing optimization, is excited to announce that it joined the membership network of The National Composites Centre (NCC), the UK research center...

4 avr 2020
Womply, a software and API company serving small businesses and app developers, today announced that it is helping American small businesses get faster access to Paycheck Protection Program loans as a verified loan agent for multiple SBA 7(a)...

4 avr 2020
Ex-Formula 1 stars Rubens Barrichello and Jan Magnussen plus esports racer Kevin Siggy were the big winners in today's Legends Trophy esports races and The Race All-Star Cup - Fully Charged by ROKiT Phones. The...



News published on 13 november 2019 at 07:05 and distributed by: